MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopaminergic neurons"

  • MDS Virtual Congress 2020

    Effects of Long-Term Treatment with Fluvoxamine on Non-Motor Symptoms and Neurogenesis in an Early Post-Natal Stress Rat Model of Parkinson’s Disease

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: To look at the long-term effects of Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), and its neuroprotection potential in a rat model of Parkinson’s…
  • MDS Virtual Congress 2020

    Parkinson’s disease and osteocalcin pilot study: Is there a protective role of bone in neurodegeneration?

    A.S Nordvig, R.N Alcalay, J.M Berger, K. Marder, G. Karsenty, A. Wang (New York, NY, USA)

    Objective: To characterize the relationship between the bone-derived hormone osteocalcin (OCN) and Parkinson’s disease (PD) in humans, and explore sex and treatment differences. Background: The…
  • MDS Virtual Congress 2020

    Effects of a next-generation neurotrophic compound in a toxin model of Parkinson’s disease

    T. Viljakainen, M. Saarma, M. Voutilainen (Helsinki, Finland)

    Objective: Investigate the effects of a peripherally administered novel neurotrophic compound, CMx01a, in 6-hydroxydopamine rat model of Parkinson’s disease. Background: Neurotrophic factors are promising drug…
  • MDS Virtual Congress 2020

    Distribution of intranasal hNSCs in a mouse model of MPTP-induced Parkinson’s disease

    F. Wang, Y.T Zhang, S.Z Wei, C. Ren, C.F Liu (Suzhou, China)

    Objective: We aimed to map the distribution of human neural stem cells (hNSCs) in the brain and peripheral tissues after intranasal administration in a mouse…
  • 2019 International Congress

    DNAJC13 in Parkinson’s disease; characterization of the p.N855S knock-in mouse model

    J. Follett, J. Fox, E. Gustavsson, M. Farrrer (Vancouver, BC, Canada)

    Objective: To study the effects of DNAJC13 p.Asn855Ser mutant gene dysfunction in a physiological context, and to help define molecular mechanisms for disease, using a…
  • 2019 International Congress

    Therapeutic intervention of LRRK2 kinase inhibitors in Vps35 p.D620N Parkinsonism

    I. Tatarnikov, J. Follett, J. Fox, M. Farrer (Vancouver, BC, Canada)

    Objective: To explore the therapeutic potential of LRRK2 kinase inhibitors in a Vps35 p.D620N mouse model of Parkinsonsim. Background: The discovery of a missense mutation, Vps35 p.D620N…
  • 2019 International Congress

    Ferroptosis, a recently identified cell death, as a therapeutic target for Parkinson’s disease.

    H. Bouchaoui, L. Mahoney-Sanchez, A. Jonneaux, F. Gouel, M. Dutheil, JC. Devedjian, G. Garçon, D. Devos (Lille, France)

    Objective: We aim to determine in a cell model neuroprotective effects of targeting lipoxygenases (LOXs), central players in Ferroptosis, a novel regulated iron-dependent cell death…
  • 2019 International Congress

    Extracellular α-synuclein enters dopaminergic neurons by modulating flotillin-1-assisted DAT endocytosis

    T. Hasegawa, J. Kobayashi, N. Sugeno, S. Yoshida, T. Akiyama, Y. Miki, M. Fukuda, M. Ezura, A. Kikuchi, T. Baba, A. Takeda, K. Wakabayashi, H. Okano, M. Aoki (Sendai, Japan)

    Objective: In this study, we examine the regulatory role of flotillin-1 in dopamine transporter (DAT) trafficking and the impact of extracellular α-synuclein (αS) on this…
  • 2019 International Congress

    Chlorogenic acid attenuates the MPTP induced apoptosis in Parkinson’s disease mouse model through pAkt signaling pathway

    S. Singh, S. Singh (Varanasi, India)

    Objective: This study deals to investigate and explore the anti-apoptotic and molecular mechanisms of CGA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinsonian mice model. Background: The debilitating…
  • 2019 International Congress

    Relative Preservation of Serotonergic Function Increases Response to Treatment in Early PD

    J. Fu, M. Matarazzo, I. Klyuzhin, K. Cheng, C. Bevington, J. Mckenzie, N. Heffernan, E. Shahinfard, M. Mckeown, AJ. Stoessl, V. Sossi (Vancouver, BC, Canada)

    Objective: To investigate interactions between the serotonergic and dopaminergic systems in early PD as related to (i) response to treatment and (ii) dopamine (DA) release,…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley